Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine

Affiliations

• ¹ Department of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
• ² Department of Hematology, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
• ³ Second Department of Internal Medicine, Hematology Unit, University General Hospital Atticon, Athens, Greece.
• ⁴ Department of Clinical Hematology, G. Gennimatas Hospital, Athens, Greece.
• ⁵ Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.
• ⁶ Department of Haematology, Aristotelion University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.
• ⁷ Department of Hematology, Theageneion Hosp. of Thessaloniki, Thessaloniki, Greece.
• ⁸ Department of Hematology, University Hospital of Heraklion, Heraklion, Greece.